• Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept 

      Ferreiro-Iglesias A., Montes A., Perez-Pampin E., Cañete J.D., Raya E., Magro-Checa C., Vasilopoulos Y., Caliz R., Ferrer M.A., Joven B., Carreira P., Balsa A., Salcedo D.P., Blanco F.J., Moreno-Ramos M.J., Manrique-Arija S., Del Carmen Ordonez M., Alegre-Sancho J.J., Narvaez J., Navarro-Sarabia F., Moreira V., Valor L., Garcia-Portales R., Marquez A., Gomez-Reino J.J., Martin J., Gonzalez A. (2019)
      Research in rheumatoid arthritis (RA) is increasingly focused on the discovery of biomarkers that could enable personalized treatments. The genetic biomarkers associated with the response to TNF inhibitors (TNFi) are among ...
    • Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis 

      Lopez-Rodriguez R., Perez-Pampin E., Marquez A., Blanco F.J., Joven B., Carreira P., Ferrer M.A., Caliz R., Valor L., Narvaez J., Cañete J.D., Del Carmen Ordoñez M., Manrique-Arija S., Vasilopoulos Y., Balsa A., Pascual-Salcedo D., Moreno-Ramos M.J., Alegre-Sancho J.J., Navarro-Sarabia F., Moreira V., Garcia-Portales R., Raya E., Magro-Checa C., Martin J., Gomez-Reino J.J., Gonzalez A. (2018)
      Genetic biomarkers are sought to personalize treatment of patients with rheumatoid arthritis (RA), given their variable response to TNF inhibitors (TNFi). However, no genetic biomaker is yet sufficiently validated. Here, ...